AAAAAA
Results:
1-24
|
Results: 24
Authors:
ECHEVERRIA D
APOSHIAN HV
WOODS JS
HEYER NJ
APOSHIAN MM
BITTNER AC
MAHURIN RK
CIANCIOLA M
Citation: D. Echeverria et al., NEUROBEHAVIORAL EFFECTS FROM EXPOSURE TO DENTAL AMALGAM HG-DEGREES - NEW DISTINCTIONS BETWEEN RECENT EXPOSURE AND HG BODY BURDEN, The FASEB journal, 12(11), 1998, pp. 971-980
Authors:
BITTNER AC
ECHEVERRIA D
WOODS JS
APOSHIAN HV
NALEWAY C
MARTIN MD
MAHURIN RK
HEYER NJ
CIANCIOLA M
Citation: Ac. Bittner et al., BEHAVIORAL-EFFECTS OF LOW-LEVEL EXPOSURE TO HG-0 AMONG DENTAL PROFESSIONALS - A CROSS-STUDY EVALUATION OF PSYCHOMOTOR EFFECTS, Neurotoxicology and teratology, 20(4), 1998, pp. 429-439
Authors:
APOSHIAN HV
Citation: Hv. Aposhian, MOBILIZATION OF MERCURY AND ARSENIC IN HUMANS BY SODIUM 2,3-DIMERCAPTO-1-PROPANE SULFONATE (DMPS), Environmental health perspectives, 106, 1998, pp. 1017-1025
Authors:
WILDFANG E
ZAKHARYAN RA
APOSHIAN HV
Citation: E. Wildfang et al., ENZYMATIC METHYLATION OF ARSENIC COMPOUNDS - VI - CHARACTERIZATION OFHAMSTER LIVER ARSENITE AND METHYLARSONIC ACID METHYLTRANSFERASE ACTIVITIES IN-VITRO, Toxicology and applied pharmacology, 152(2), 1998, pp. 366-375
Authors:
HEALY SM
CASAREZ EA
AYALAFIERRO F
APOSHIAN HV
Citation: Sm. Healy et al., ENZYMATIC METHYLATION OF ARSENIC COMPOUNDS V - ARSENITE METHYLTRANSFERASE ACTIVITY IN TISSUES OF MICE, Toxicology and applied pharmacology, 148(1), 1998, pp. 65-70
Authors:
GONZALEZRAMIREZ D
ZUNIGACHARLES M
NARROJUAREZ A
MOLINARECIO Y
HURLBUT KM
DART RC
APOSHIAN HV
Citation: D. Gonzalezramirez et al., DMPS (2,3-DIMERCAPTOPROPANE-1-SULFONATE, DIMAVAL) DECREASES THE BODY BURDEN OF MERCURY IN HUMANS EXPOSED TO MERCUROUS CHLORIDE, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 8-12
Authors:
HEALY SM
ZAKHARYAN RA
APOSHIAN HV
Citation: Sm. Healy et al., ENZYMATIC METHYLATION OF ARSENIC COMPOUNDS - IV - IN-VITRO AND IN-VIVO DEFICIENCY OF THE METHYLATION OF ARSENITE AND MONOMETHYLARSONIC ACIDIN THE GUINEA-PIG (VOL 386, PG 229, 1997), Mutation research-reviews in mutation research, 387(3), 1997, pp. 173-173
Authors:
HEALY SM
ZAKHARYAN RA
APOSHIAN HV
Citation: Sm. Healy et al., ENZYMATIC METHYLATION OF ARSENIC COMPOUNDS .4. IN-VITRO AND IN-VIVO DEFICIENCY OF THE METHYLATION OF ARSENITE AND MONOMETHYLARSONIC ACID INTHE GUINEA-PIG, Mutation research-reviews in mutation research, 386(3), 1997, pp. 229-239
Authors:
APOSHIAN HV
Citation: Hv. Aposhian, ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITY, Annual review of pharmacology and toxicology, 37, 1997, pp. 397-419
Authors:
KEITH RL
SETIARAHARDJO I
FERNANDO Q
APOSHIAN HV
GANDOLFI AJ
Citation: Rl. Keith et al., UTILIZATION OF RENAL SLICES TO EVALUATE THE EFFICACY OF CHELATING-AGENTS FOR REMOVING MERCURY FROM THE KIDNEY, Toxicology, 116(1-3), 1997, pp. 67-75
Authors:
APOSHIAN HV
ARROYO A
CEBRIAN ME
DELRAZO LM
HURLBUT KM
DART RC
GONZALEZRAMIREZ D
KREPPEL H
SPEISKY H
SMITH A
GONSEBATT ME
OSTROSKYWEGMAN P
APOSHIAN MM
Citation: Hv. Aposhian et al., DMPS-ARSENIC CHALLENGE TEST .1. INCREASED URINARY-EXCRETION OF MONOMETHYLARSONIC ACID IN HUMANS GIVEN DIMERCAPTOPROPANE SULFONATE, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 192-200
Authors:
APOSHIAN MM
MAIORINO RM
XU ZF
APOSHIAN HV
Citation: Mm. Aposhian et al., SODIUM 2,3-DIMERCAPTO-1-PROPANESULFONATE (DMPS) TREATMENT DOES NOT REDISTRIBUTE LEAD OR MERCURY TO THE BRAIN OF RATS, Toxicology, 109(1), 1996, pp. 49-55
Authors:
ZAKHARYAN RA
WILDFANG E
APOSHIAN HV
Citation: Ra. Zakharyan et al., ENZYMATIC METHYLATION OF ARSENIC COMPOUNDS .3. THE MARMOSET AND TAMARIN, BUT NOT THE RHESUS, MONKEYS ARE DEFICIENT IN METHYLTRANSFERASES THAT METHYLATE INORGANIC ARSENIC, Toxicology and applied pharmacology, 140(1), 1996, pp. 77-84
Authors:
MAIORINO RM
GONZALEZRAMIREZ D
ZUNIGACHARLES M
XU ZF
HURLBUT KM
APOSHIAN MM
DART RC
WOODS JS
OSTROSKYWEGMAN P
GONSEBATT ME
APOSHIAN HV
Citation: Rm. Maiorino et al., SODIUM 2,3-DIMERCAPTOPROPANE-1-SULFONATE CHALLENGE TEST FOR MERCURY IN HUMANS .3. URINARY MERCURY AFTER EXPOSURE TO MERCUROUS CHLORIDE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 938-944
Authors:
MAIORINO RM
XU ZF
APOSHIAN HV
Citation: Rm. Maiorino et al., DETERMINATION AND METABOLISM OF DITHIOL CHELATING-AGENTS .17. IN HUMANS, SODIUM 2,3-DIMERCAPTO-1-PROPANESULFONATE IS BOUND TO PLASMA-ALBUMIN VIA MIXED DISULFIDE FORMATION AND IS FOUND IN THE URINE AS CYCLIC POLYMERIC DISULFIDES, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 375-384
Authors:
ZAKHARYAN R
WU Y
BOGDAN GM
APOSHIAN HV
Citation: R. Zakharyan et al., ENZYMATIC METHYLATION OF ARSENIC COMPOUNDS - ASSAY, PARTIAL-PURIFICATION, AND PROPERTIES OF ARSENITE METHYLTRANSFERASE AND MONOMETHYLARSONIC ACID METHYLTRANSFERASE OF RABBIT LIVER, Chemical research in toxicology, 8(8), 1995, pp. 1029-1038
Authors:
APOSHIAN HV
Citation: Hv. Aposhian, NEUROTOXICITY OF METALS - THE NEW CHALLENGES - INTRODUCTORY-REMARKS, Toxicology, 97(1-3), 1995, pp. 1-2
Authors:
APOSHIAN HV
MAIORINO RM
GONZALEZRAMIREZ D
ZUNIGACHARLES M
XU ZF
HURLBUT KM
JUNCOMUNOZ P
DART RC
APOSHIAN MM
Citation: Hv. Aposhian et al., MOBILIZATION OF HEAVY-METALS BY NEWER, THERAPEUTICALLY USEFUL CHELATING-AGENTS, Toxicology, 97(1-3), 1995, pp. 23-38
Authors:
INGERSOLL RT
MONTGOMERY EB
APOSHIAN HV
Citation: Rt. Ingersoll et al., CENTRAL-NERVOUS-SYSTEM TOXICITY OF MANGANESE .1. INHIBITION OF SPONTANEOUS MOTOR-ACTIVITY IN RATS AFTER INTRATHECAL ADMINISTRATION OF MANGANESE CHLORIDE, Fundamental and applied toxicology, 27(1), 1995, pp. 106-113
Authors:
GONZALEZRAMIREZ D
MAIORINO RM
ZUNIGACHARLES M
XU ZF
HURLBUT KM
JUNCOMUNOZ P
APOSHIAN MM
DART RC
GAMA JHD
ECHEVERRIA D
WOODS JS
APOSHIAN HV
Citation: D. Gonzalezramirez et al., SODIUM 2,3-DIMERCAPTOPROPANE-1-SULFONATE CHALLENGE TEST FOR MERCURY IN HUMANS .2. URINARY MERCURY, PORPHYRINS AND NEUROBEHAVIORAL CHANGES OF DENTAL WORKERS IN MONTERREY, MEXICO, The Journal of pharmacology and experimental therapeutics, 272(1), 1995, pp. 264-274
Authors:
BOGDAN GM
SAMPAYOREYES A
APOSHIAN HV
Citation: Gm. Bogdan et al., ARSENIC BINDING-PROTEINS OF MAMMALIAN SYSTEMS .1. ISOLATION OF 3 ARSENITE-BINDING PROTEINS OF RABBIT LIVER, Toxicology, 93(2-3), 1994, pp. 175-193
Authors:
HURLBUT KM
MAIORINO RM
MAYERSOHN M
DART RC
BRUCE DC
APOSHIAN HV
Citation: Km. Hurlbut et al., DETERMINATION AND METABOLISM OF DITHIOL CHELATING-AGENTS .XVI. PHARMACOKINETICS OF 2,3-DIMERCAPTO-1-PROPANESULFONATE AFTER INTRAVENOUS ADMINISTRATION TO HUMAN VOLUNTEERS, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 662-668
Authors:
DART RC
HURLBUT KM
MAIORINO RM
MAYERSOHN M
APOSHIAN HV
HASSEN LVB
Citation: Rc. Dart et al., PHARMACOKINETICS OF MESO-2,3-DIMERCAPTOSUCCINIC ACID IN PATIENTS WITHLEAD-POISONING AND IN HEALTHY-ADULTS, The Journal of pediatrics, 125(2), 1994, pp. 309-316
Authors:
MAIORINO RM
APOSHIAN MM
XU ZF
LI YS
POLT RL
APOSHIAN HV
Citation: Rm. Maiorino et al., DETERMINATION AND METABOLISM OF DITHIOL CHELATING-AGENTS .15. THE MESO-2,3-DIMERCAPTOSUCCINIC ACID-CYSTEINE (1 2) MIXED DUSULFIDE, A MAJOR URINARY METABOLITE OF DMSA IN THE HUMAN, INCREASES THE URINARY-EXCRETION OF LEAD IN THE RAT/, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1221-1226
Risultati:
1-24
|